StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core structure exploration tiers

Rule-based Catalog Exploration Score from SMILES similarity, approved/clinical tags, family network size, and SAR metadata. It does not predict efficacy, safety, or development success.

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Core 후보 59파생 후보 24041 패밀리

HighHigh exploration priority9

Highest Exploration Score percentile in this pool (X-S bin)

High exploration priority2DStructureClassExploration ScoreFactors
High
4-Anilinoquinazoline EGFR core
EGFR tyrosine kinase inhibitor series · Scaffold
EGFR TKI100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
Aminobenzothiazole core
ALS neuroprotectant series · Scaffold
ALS100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
Aryloxy-propylamine core
SSRI / SNRI antidepressant series · Scaffold
Antidepressant · SSRI/SNRI100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
BTK pyrazolo-pyrimidine core
BTK inhibitor chemical series · Scaffold
BTK inhibitor100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
Catecholamine / amino-acid core
Parkinson dopaminergic / MAO-B series · Scaffold
Parkinson100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
Daraxonrasib core (acrylic warhead scaffold)
Daraxonrasib scaffold family · Scaffold
KRAS inhibitor100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
Dolastatin 10 / auristatin core
MMAE (auristatin) payload family · Scaffold
ADC payload100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
Gabapentinoid amino-acid core
Neuropathic gabapentinoid / SNRI series · Scaffold
Neuropathic · gabapentinoid100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
High
KRAS G12C warhead (acrylamide pharmacophore)
KRAS G12C inhibitor chemical landscape · Scaffold
KRAS inhibitor100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

EGFR tyrosine kinase inhibitor series · Scaffold · EGFR TKI

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

ALS neuroprotectant series · Scaffold · ALS

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

SSRI / SNRI antidepressant series · Scaffold · Antidepressant · SSRI/SNRI

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

BTK inhibitor chemical series · Scaffold · BTK inhibitor

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Parkinson dopaminergic / MAO-B series · Scaffold · Parkinson

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Neuropathic gabapentinoid / SNRI series · Scaffold · Neuropathic · gabapentinoid

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

MedMedium exploration priority15

Upper-mid Exploration Score percentile (X-A bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
KRAS G12D core scaffold
KRAS G12D / RAS(ON) inhibitor series · Scaffold
KRAS inhibitor100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
N-benzylpiperidine pharmacophore
Cognitive modulator series · Scaffold
Cognition · dementia100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
PARP nicotinamide pharmacophore
PARP inhibitor chemical series · Scaffold
PARP inhibitor100패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
BRAF hinge-binding aryl core
BRAF / MEK inhibitor chemical series · Scaffold
BRAF / MEK99패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Duocarmycin CPI core
Duocarmycin CPI ADC payload series · Scaffold
ADC payload99패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Phenylaminopyrimidine kinase core
BCR-ABL TKI chemical series · Scaffold
BCR-ABL TKI99패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Pyrrolopyrimidine CDK4/6 core
CDK4/6 inhibitor chemical series · Scaffold
CDK4/6 inhibitor99패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
ALK aminopyridine pharmacophore
ALK / ROS1 TKI chemical series · Scaffold
ALK / ROS1 TKI98패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Camptothecin (parent alkaloid)
SN-38 / irinotecan (TOP1) small-molecule series · Scaffold
TOP1 inhibitor98패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Camptothecin / exatecan core
Exatecan / DXd (TOP1 inhibitor) payload family · Scaffold
TOP1 inhibitor97패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Enediyne warhead core
Calicheamicin enediyne payload family · Scaffold
ADC payload96패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
GLP-1 incretin pharmacophore
GLP-1 / incretin agonist series · Scaffold
GLP-1 / incretin96패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
PBD monomer (anthramycin lineage)
PBD dimer ADC payload family · Scaffold
ADC payload96패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
PCSK9-binding macrocyclic peptide pharmacophore
PCSK9 inhibitor chemical & modality series · Scaffold
PCSK9 / LDL-C96패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
1,4-Benzodiazepine core
Benzodiazepine GABA-A modulators · Scaffold
Anxiolytic · GABA95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

KRAS G12D / RAS(ON) inhibitor series · Scaffold · KRAS inhibitor

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

BRAF / MEK inhibitor chemical series · Scaffold · BRAF / MEK

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Duocarmycin CPI ADC payload series · Scaffold · ADC payload

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

CDK4/6 inhibitor chemical series · Scaffold · CDK4/6 inhibitor

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

SN-38 / irinotecan (TOP1) small-molecule series · Scaffold · TOP1 inhibitor

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Exatecan / DXd (TOP1 inhibitor) payload family · Scaffold · TOP1 inhibitor

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Calicheamicin enediyne payload family · Scaffold · ADC payload

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

GLP-1 / incretin agonist series · Scaffold · GLP-1 / incretin

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Benzodiazepine GABA-A modulators · Scaffold · Anxiolytic · GABA

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

MedMedium exploration priority23

Mid-pool Exploration Score (X-B bin)

High exploration priority2DStructureClassExploration ScoreFactors
Med
Bifunctional degrader scaffold (E3 recruiter)
PROTAC / bifunctional degrader series · Scaffold
PROTAC / degrader95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Cleavable linker scaffold
ADC linker chemical families · Scaffold
ADC linker95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Imidazopyridine pharmacophore
Sleep / hypnotic series · Scaffold
Sleep · hypnotic95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Indole tryptamine pharmacophore
Migraine triptan series · Scaffold
Migraine · triptan95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Morpholino-pyrimidine PI3K pharmacophore
PI3K / AKT / mTOR inhibitor series · Scaffold
PI3K / AKT / mTOR95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Multi-kinase hinge core
RET / MET / NTRK oncogene TKI series · Scaffold
RET / MET / NTRK TKI95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Phenethylamine pharmacophore
ADHD stimulant / non-stimulant series · Scaffold
ADHD95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Pyrrolidinone carboxamide core
Antiepileptic drug chemical series · Scaffold
Antiepileptic · AED95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Sphingosine-like pharmacophore
MS S1P modulator series · Scaffold
MS · S1P95패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
BH3-mimetic scaffold
BCL-2 BH3-mimetic inhibitor series · Scaffold
BCL-2 inhibitor94패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
C-glucoside SGLT2 pharmacophore
SGLT2 inhibitor series · Scaffold
SGLT2 inhibitor94패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Dihydroxyheptanoate pharmacophore
Statin HMG-CoA reductase inhibitor series · Scaffold
Statin / HMG-CoA94패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Piperazine aryl pharmacophore
Atypical antipsychotic series · Scaffold
Antipsychotic94패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Pyrrolopyrimidine JAK core
JAK inhibitor chemical series · Scaffold
JAK inhibitor94패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
CGRP urea / amide pharmacophore
CGRP gepant migraine series · Scaffold
Migraine · CGRP gepant93패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Maytansine core
DM1 / maytansinoid payload family · Scaffold
Maytansinoid93패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
MMAE (monomethyl auristatin E)
MMAE (auristatin) payload family · Payload
ADC payload91Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종
Med
DXd (deruxtecan payload)
Exatecan / DXd (TOP1 inhibitor) payload family · Payload
TOP1 inhibitor89Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종
Med
Taxane tetracyclic core
Taxane diterpenoid series · Scaffold
Taxane / microtubule86패밀리 core · Pharmacophore · SMILES 확보 · SAR/core
Med
Dara-P1 (ADC payload)
Daraxonrasib scaffold family · Payload
KRAS inhibitor68Payload core · SMILES 확보 · 패밀리 15종 · 파생 2건
Med
Dara-P2 (ADC payload)
Daraxonrasib scaffold family · Payload
KRAS inhibitor68Payload core · SMILES 확보 · 패밀리 15종 · 파생 2건
Med
Dara-P3 (next-gen payload)
Daraxonrasib scaffold family · Payload
KRAS inhibitor65Payload core · SMILES 확보 · 패밀리 15종 · 고관심 계열
Med
Duocarmycin SA
Duocarmycin CPI ADC payload series · Payload
ADC payload64Payload core · SMILES 확보 · 파생 2건 · 고관심 계열

ADC linker chemical families · Scaffold · ADC linker

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Sleep / hypnotic series · Scaffold · Sleep · hypnotic

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

RET / MET / NTRK oncogene TKI series · Scaffold · RET / MET / NTRK TKI

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

ADHD stimulant / non-stimulant series · Scaffold · ADHD

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Antiepileptic drug chemical series · Scaffold · Antiepileptic · AED

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

BCL-2 BH3-mimetic inhibitor series · Scaffold · BCL-2 inhibitor

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Statin HMG-CoA reductase inhibitor series · Scaffold · Statin / HMG-CoA

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Atypical antipsychotic series · Scaffold · Antipsychotic

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

JAK inhibitor chemical series · Scaffold · JAK inhibitor

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

CGRP gepant migraine series · Scaffold · Migraine · CGRP gepant

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

DM1 / maytansinoid payload family · Scaffold · Maytansinoid

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

MMAE (auristatin) payload family · Payload · ADC payload

Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종

Exatecan / DXd (TOP1 inhibitor) payload family · Payload · TOP1 inhibitor

Payload core · SMILES 확보 · 승인·상용 신호 · 패밀리 12종

Taxane diterpenoid series · Scaffold · Taxane / microtubule

패밀리 core · Pharmacophore · SMILES 확보 · SAR/core

Daraxonrasib scaffold family · Payload · KRAS inhibitor

Payload core · SMILES 확보 · 패밀리 15종 · 파생 2건

Daraxonrasib scaffold family · Payload · KRAS inhibitor

Payload core · SMILES 확보 · 패밀리 15종 · 파생 2건

Daraxonrasib scaffold family · Payload · KRAS inhibitor

Payload core · SMILES 확보 · 패밀리 15종 · 고관심 계열

Duocarmycin CPI ADC payload series · Payload · ADC payload

Payload core · SMILES 확보 · 파생 2건 · 고관심 계열

LowLow exploration priority29

Lower Exploration Score — still listed for inspection (X-C bin)

High exploration priority2DStructureClassExploration ScoreFactors
Low
MMAF (monomethyl auristatin F)
MMAE (auristatin) payload family · Payload
ADC payload64Payload core · SMILES 확보 · 패밀리 12종 · 고관심 계열
Low
N-acetyl-γ-calicheamicin
Calicheamicin enediyne payload family · Payload
ADC payload64Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Low
SG3199 (PBD dimer warhead)
PBD dimer ADC payload family · Payload
ADC payload64Payload core · SMILES 확보 · 파생 2건 · 고관심 계열
Low
Auristatin E (parent)
MMAE (auristatin) payload family · Scaffold
ADC payload63Pharmacophore · SMILES 확보 · 패밀리 12종 · 고관심 계열
Low
DM1 (mertansine)
DM1 / maytansinoid payload family · Payload
Maytansinoid63Payload core · SMILES 확보 · 패밀리 9종 · 파생 3건
Low
Calicheamicin γ¹
Calicheamicin enediyne payload family · Payload
ADC payload61Payload core · SMILES 확보 · 고관심 계열
Low
KRAS-targeted payload analog 1
KRAS G12C inhibitor chemical landscape · Payload
KRAS inhibitor61Payload core · SMILES 확보 · 패밀리 13종 · 고관심 계열
Low
Tesirine (SG3249)
PBD dimer ADC payload family · Payload
ADC payload61Payload core · SMILES 확보 · 고관심 계열
Low
SMCC
Daraxonrasib scaffold family · Linker
KRAS inhibitor60Linker hub · SMILES 확보 · 패밀리 15종 · 고관심 계열
Low
Sulfo-SPDB
Daraxonrasib scaffold family · Linker
KRAS inhibitor60Linker hub · SMILES 확보 · 패밀리 15종 · 고관심 계열
Low
Mc-VC-PABC
Daraxonrasib scaffold family · Linker
KRAS inhibitor58Linker hub · SMILES 확보 · 패밀리 15종 · 고관심 계열
Low
Seco-duocarmycin
Duocarmycin CPI ADC payload series · Payload
ADC payload56Payload core · SMILES 확보 · 고관심 계열
Low
DM4 (soravtansine)
DM1 / maytansinoid payload family · Payload
Maytansinoid55Payload core · SMILES 확보 · 패밀리 9종
Low
SN-38 payload (cross-family)
DM1 / maytansinoid payload family · Payload
Maytansinoid55Payload core · SMILES 확보 · 패밀리 9종
Low
Val-Cit
MMAE (auristatin) payload family · Linker
ADC payload55Linker hub · SMILES 확보 · 패밀리 12종 · 고관심 계열
Low
SN-38 ADC linker-payload design
SN-38 / irinotecan (TOP1) small-molecule series · Payload
TOP1 inhibitor53Payload core · SMILES 확보
Low
Acyl hydrazone linker
Calicheamicin enediyne payload family · Linker
ADC payload52Linker hub · SMILES 확보 · 고관심 계열
Low
Val-Ala PBD linker
PBD dimer ADC payload family · Linker
ADC payload52Linker hub · SMILES 확보 · 고관심 계열
Low
Duocarmycin Val-Cit linker node
Duocarmycin CPI ADC payload series · Linker
ADC payload50Linker hub · SMILES 확보 · 고관심 계열
Low
GGFG (cleavable linker)
Exatecan / DXd (TOP1 inhibitor) payload family · Linker
TOP1 inhibitor49Linker hub · SMILES 확보 · 패밀리 12종
Low
CL2A (lysine-cleavable linker)
Exatecan / DXd (TOP1 inhibitor) payload family · Linker
TOP1 inhibitor47Linker hub · SMILES 확보 · 패밀리 12종
Low
Mc-VC-PABC family
ADC linker chemical families · Linker
ADC linker47Linker hub · SMILES 확보 · 패밀리 8종
Low
Val-Cit family
ADC linker chemical families · Linker
ADC linker47Linker hub · SMILES 확보 · 패밀리 8종
Low
CL2A family
ADC linker chemical families · Linker
ADC linker45Linker hub · SMILES 확보 · 패밀리 8종
Low
GGFG family
ADC linker chemical families · Linker
ADC linker45Linker hub · SMILES 확보 · 패밀리 8종
Low
SMCC family
ADC linker chemical families · Linker
ADC linker45Linker hub · SMILES 확보 · 패밀리 8종
Low
Sulfo-SPDB family
ADC linker chemical families · Linker
ADC linker45Linker hub · SMILES 확보 · 패밀리 8종
Low
SMCC-DM1 (linker-payload)
DM1 / maytansinoid payload family · Linker
Maytansinoid44Linker hub · SMILES 확보 · 패밀리 9종
Low
Hydrazone family
ADC linker chemical families · Linker
ADC linker43Linker hub · SMILES 확보 · 패밀리 8종

MMAE (auristatin) payload family · Payload · ADC payload

Payload core · SMILES 확보 · 패밀리 12종 · 고관심 계열

Calicheamicin enediyne payload family · Payload · ADC payload

Payload core · SMILES 확보 · 파생 2건 · 고관심 계열

PBD dimer ADC payload family · Payload · ADC payload

Payload core · SMILES 확보 · 파생 2건 · 고관심 계열

MMAE (auristatin) payload family · Scaffold · ADC payload

Pharmacophore · SMILES 확보 · 패밀리 12종 · 고관심 계열

DM1 / maytansinoid payload family · Payload · Maytansinoid

Payload core · SMILES 확보 · 패밀리 9종 · 파생 3건

Calicheamicin enediyne payload family · Payload · ADC payload

Payload core · SMILES 확보 · 고관심 계열

KRAS G12C inhibitor chemical landscape · Payload · KRAS inhibitor

Payload core · SMILES 확보 · 패밀리 13종 · 고관심 계열

PBD dimer ADC payload family · Payload · ADC payload

Payload core · SMILES 확보 · 고관심 계열

LowSMCC

Daraxonrasib scaffold family · Linker · KRAS inhibitor

Linker hub · SMILES 확보 · 패밀리 15종 · 고관심 계열

Daraxonrasib scaffold family · Linker · KRAS inhibitor

Linker hub · SMILES 확보 · 패밀리 15종 · 고관심 계열

Daraxonrasib scaffold family · Linker · KRAS inhibitor

Linker hub · SMILES 확보 · 패밀리 15종 · 고관심 계열

Duocarmycin CPI ADC payload series · Payload · ADC payload

Payload core · SMILES 확보 · 고관심 계열

DM1 / maytansinoid payload family · Payload · Maytansinoid

Payload core · SMILES 확보 · 패밀리 9종

MMAE (auristatin) payload family · Linker · ADC payload

Linker hub · SMILES 확보 · 패밀리 12종 · 고관심 계열

Calicheamicin enediyne payload family · Linker · ADC payload

Linker hub · SMILES 확보 · 고관심 계열

PBD dimer ADC payload family · Linker · ADC payload

Linker hub · SMILES 확보 · 고관심 계열

Exatecan / DXd (TOP1 inhibitor) payload family · Linker · TOP1 inhibitor

Linker hub · SMILES 확보 · 패밀리 12종

Exatecan / DXd (TOP1 inhibitor) payload family · Linker · TOP1 inhibitor

Linker hub · SMILES 확보 · 패밀리 12종

ADC linker chemical families · Linker · ADC linker

Linker hub · SMILES 확보 · 패밀리 8종

ADC linker chemical families · Linker · ADC linker

Linker hub · SMILES 확보 · 패밀리 8종

ADC linker chemical families · Linker · ADC linker

Linker hub · SMILES 확보 · 패밀리 8종

ADC linker chemical families · Linker · ADC linker

Linker hub · SMILES 확보 · 패밀리 8종

ADC linker chemical families · Linker · ADC linker

Linker hub · SMILES 확보 · 패밀리 8종

ADC linker chemical families · Linker · ADC linker

Linker hub · SMILES 확보 · 패밀리 8종

DM1 / maytansinoid payload family · Linker · Maytansinoid

Linker hub · SMILES 확보 · 패밀리 9종

ADC linker chemical families · Linker · ADC linker

Linker hub · SMILES 확보 · 패밀리 8종

Exploration score method

StructureMoa ranks are a rule-based Exploration Score. An LLM does not predict activity or efficacy. Role, SMILES, and relation signals inside each family are summed and cut into High / Medium / Low exploration priority.

Core tab

  • scaffold / payload / linker role weights
  • family center-compound bonus
  • SMILES source (db · known · pubchem · inherited)
  • relation-edge count and derived-child count

Derivative tab

  • drug / derivative / adc candidates
  • similarity to family center via Morgan fingerprint, radius 2, 2048 bits, Tanimoto
  • approved / clinical catalog-tag bonuses
  • ADC / payload tags

Explore tab

  • sparse SAR, cross-scaffold pairs, expansion leaves
  • weakly linked nodes and approved-tag neighborhood gaps
  • relation graph + stored Morgan fingerprints
  • category filters

Exploration-priority bins

  • High (X-S): top ~12%
  • Medium (X-A/X-B): ~12–62%
  • Low (X-C): remainder (pools under 5 compounds stay Medium)

Internal exploration metric based on catalog and structural signals. Not a prediction of efficacy, safety, potency, or development success.

Full methodology

평가 시각: 2026. 9. 11. 오전 4:01:55 · 캐시 5분 · 전체 패밀리